Skip to Content

Tag: Medtronics

Also Noted

MiniMed analysis shows high rates of time in range

June 3, 2021HME News Staff

DUBLIN, Ireland – Diabetes patients using Medtronics’ MiniMed 780G system saw an average overall time in range of 76.2% and an overnight time in range of 83%, according to an analysis of 4,120 individuals with Type 1 diabetes. "It is extremely encouraging to see Medtronic advancing both clinical outcomes, as well as the user experience through their latest MiniMed 780G system,” said Prof. Chantal Mathieu, endocrinologist at University Hospitals Leuven-KULeuven, Belgium. “It...

Medtronics, Type 1 Diabetes

Read Full Articlered right arrow icon